Follow this innovation
[ via 
] [?]
Innovation
Use of Dexatromethorphan; Sodium Benzoate, Phenylacetate and Phenylbuterate to Treat Autism Associated with Increased Levels of Glutamine and Glycine.
Vanderbilt University
posted on 10/31/2008
-
Innovation Details
Detailed Description
CONTACT
Janis Elsner
615.322.7056
janis.elsner@vanderbilt.edu
File Number: VU9944
Other Information:
Principal Investigator: John Phillips
IP Protection
| Patent Information: | None issued. |
|---|---|
| Additional Patents: | No |
License Online
This innovation currently is not available for online licensing. Please contact the case manager at Vanderbilt University for more information.
request more info
ProfileFind more innovations
